Alessandro Spirito, Dipti Itchhaporia, Samantha Sartori, Edoardo Camenzind, Alaide Chieffo, George D Dangas, Soren Galatius, Raban V Jeger, David E Kandzari, Adnan Kastrati, Hyo-Soo Kim, Takeshi Kimura, Martin B Leon, Laxmi S Mehta, Ghada W Mikhail, Marie-Claude Morice, Johny Nicolas, Brunna Pileggi, Patrick W Serruys, Pieter C Smits, P Gabriel Steg, Gregg W Stone, Marco Valgimigli, Birgit Vogel, Clemens von Birgelen, Giora Weisz, William Wijns, Stephan Windecker, Roxana Mehran
BACKGROUND: For women undergoing drug-eluting stent (DES) implantation, the individual and combined impact of chronic kidney disease (CKD) and diabetes mellitus (DM) on outcomes is uncertain. AIMS: We sought to assess the impact of CKD and DM on prognosis in women after DES implantation. METHODS: We pooled patient-level data on women from 26 randomised controlled trials comparing stent types. Women receiving DES were stratified into 4 groups based on CKD (defined as creatine clearance <60 mL/min) and DM status...
June 28, 2023: EuroIntervention